EC OPHTHALMOLOGY Published Research Article – The Post-Vitrectomy Lenstatin™ Study: A Randomized Double Blind Human Clinical Trial Testing the Efficacy of Lenstatin, an Oral Antioxidant Nutritional Supplement, in Inhibiting Nuclear Cataract Progression After Pars Plana Vitrectomy

ECOP-09-00302_LS Published Manuscript Abstract The Post-Vitrectomy Lenstatin™ Study was a randomized, prospective, double-blind, placebo controlled human clinical trial to test the efficacy of Lenstatin, a proprietary antioxidant nutritional supplement, in…

The Post-Vitrectomy Lenstatin Study

Description To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy. Specialties: Physician Assistant: Clinical Pharmacology, Ophthalmology, Ophthalmology:…